Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Verification of Reference Standards and Working Standards – V 2.0

Posted on By

Analytical Method Development: SOP for Verification of Reference Standards and Working Standards – V 2.0

Procedure for Qualification of Reference and Working Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/356/2025
Supersedes SOP/AMD/356/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2027

1. Purpose

This Standard Operating Procedure (SOP) outlines the processes for the qualification, approval, handling, labeling, documentation, and storage of primary Reference Standards (RS) and Working Standards (WS) in the Analytical Method Development (AMD) laboratory.

2. Scope

This

SOP applies to all reference standards procured from recognized pharmacopeial sources or certified manufacturers and working standards prepared internally at the AMD laboratory of API and formulation facilities.

3. Responsibilities

  • Analytical Chemist: Responsible for preparation, qualification, and maintenance of WS from RS.
  • QA Department: Verifies qualification protocol, reviews documentation, and approves WS usage.
  • AMD Head: Authorizes RS and WS qualification reports and ensures regulatory compliance.
See also  Analytical Method Development: SOP for In-Vitro Release Testing for Topical Products - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the scientific integrity, regulatory compliance, and traceability of reference and working standards in the laboratory.

5. Procedure

5.1 Procurement and Receipt of RS

  1. Procure RS from official sources (USP, BP, EP, Ph. Eur., IP, WHO, NIB).
  2. On receipt, check packaging integrity, certificate of analysis (CoA), and batch number.
  3. Label as “Reference Standard – For Laboratory Use Only” with date of receipt and expiry.

5.2 Storage of RS

  1. Store as per label conditions (e.g., 2–8°C, protect from light, desiccator, etc.).
  2. Ensure temperature and humidity-controlled environment for stability.
  3. Maintain RS Stock Register (Annexure-1) with quantity, batch number, and expiry.

5.3 Preparation of WS from RS

  1. Weigh appropriate amount of RS with analytical balance having 4-decimal precision.
  2. Dilute with suitable solvent to prepare stock solution at required concentration.
  3. Divide into amber glass vials and label with WS code, potency, preparation date, and retest date.
  4. Store WS in refrigerated condition or as required based on stability data.

5.4 Qualification of WS

  1. Compare WS performance against RS in at least three analytical parameters (e.g., assay, purity, retention time, area response).
  2. Ensure results are within acceptable variation limit (typically ±2%).
  3. Record qualification results in WS Qualification Template (Annexure-2).
  4. QA to review and approve before first-time usage in routine analysis or method validation.
See also  Analytical Method Development: Suitability Testing for Microbial Methods - V 2.0

5.5 Retest and Requalification

  1. Assign retest period of 6 or 12 months based on WS stability or ICH Q1 guidelines.
  2. Prior to expiry or retest date, perform comparative analysis again with fresh RS.
  3. Destroy WS immediately if it fails requalification or physical inspection criteria.

5.6 Documentation and Traceability

  1. Maintain RS CoAs, WS preparation records, usage logs, and calibration curves in secure binders or validated LIMS.
  2. Generate internal identification numbers for all RS/WS for traceability across reports.
  3. Ensure logbook entries are reviewed and countersigned.

6. Abbreviations

  • RS: Reference Standard
  • WS: Working Standard
  • CoA: Certificate of Analysis
  • QA: Quality Assurance
  • LIMS: Laboratory Information Management System

7. Documents

  1. Annexure-1: Reference Standard Stock Register
  2. Annexure-2: Working Standard Qualification Template
  3. Annexure-3: WS Usage Log

8. References

  • ICH Q6A: Specifications: Test Procedures and Acceptance Criteria
  • USP <11> – Reference Standards
  • Ph. Eur. Chapter 5.12 – Reference Standards
  • 21 CFR Part 211.194 – Laboratory Records

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ravi Tiwari Neha Sharma Dr. R. K. Sinha
Designation Analyst – AMD QA Executive Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Reference Standard Stock Register

RS Code Material Name Source Batch No. Expiry Quantity Storage
RS-001 Paracetamol USP 22APC001 Dec-2026 1 g 2–8°C

Annexure-2: Working Standard Qualification Template

Include: RS vs WS comparison, chromatogram overlays, peak area values, assay comparison, conclusion, and QA comments.

Annexure-3: WS Usage Log

Date WS Code Analyst Purpose Qty Used Balance Signature
01/06/2025 WS-PCT-001 A. Kumar Method Validation 50 mg 950 mg

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Added requalification procedure and usage log format Annual Review Dr. R. K. Sinha
01/05/2022 1.0 Initial Release New SOP QA Head
See also  Analytical Method Development: Review and Approval of Method Development Data - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0
Next Post: Elixir Department: SOP for SOP Review and Control – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version